Cargando…
PTEN Inhibition in Human Disease Therapy
The tumor suppressor PTEN is a major homeostatic regulator, by virtue of its lipid phosphatase activity against phosphatidylinositol 3,4,5-trisphosphate [PI(3,4,5)P3], which downregulates the PI3K/AKT/mTOR prosurvival signaling, as well as by its protein phosphatase activity towards specific protein...
Autor principal: | Pulido, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017825/ https://www.ncbi.nlm.nih.gov/pubmed/29385737 http://dx.doi.org/10.3390/molecules23020285 |
Ejemplares similares
-
Novel anti-PTEN C2 domain monoclonal antibodies to analyse the expression and function of PTEN isoform variants
por: Torices, Leire, et al.
Publicado: (2023) -
A Functional Dissection of PTEN N-Terminus: Implications in PTEN Subcellular Targeting and Tumor Suppressor Activity
por: Gil, Anabel, et al.
Publicado: (2015) -
Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function
por: Fernández-Acero, Teresa, et al.
Publicado: (2019) -
PTEN inhibition and axon regeneration and neural repair
por: Ohtake, Yosuke, et al.
Publicado: (2015) -
PTEN, Longevity and Age-Related Diseases
por: Tait, Izak S., et al.
Publicado: (2013)